Cargando…
Widely metastatic IDH1-mutant glioblastoma with oligodendroglial features and atypical molecular findings: a case report and review of current challenges in molecular diagnostics
BACKGROUND: Gliomas with 1p/19q-codeletion as well as mutation of isocitrate dehydrogenase (IDH) 1 are typically characterized as oligodendrogliomas with comparatively good response to treatment with radiation and chemotherapy. CASE PRESENTATION: We present the case of a 28-year-old man with an IDH1...
Autores principales: | Romo, Carlos G., Palsgrove, Doreen N., Sivakumar, Ananyaa, Elledge, Christen R., Kleinberg, Lawrence R., Chaichana, Kaisorn L., Gocke, Christopher D., Rodriguez, Fausto J., Holdhoff, Matthias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6368694/ https://www.ncbi.nlm.nih.gov/pubmed/30738431 http://dx.doi.org/10.1186/s13000-019-0793-5 |
Ejemplares similares
-
Molecular classification of IDH-mutant glioblastomas based on gene expression profiles
por: Wu, Fan, et al.
Publicado: (2019) -
Spatial progression and molecular heterogeneity of IDH-mutant glioblastoma determined by DNA methylation-based mapping
por: Lyon, James F., et al.
Publicado: (2021) -
The consistency of neuropathological diagnoses in patients undergoing surgery for suspected recurrence of glioblastoma
por: Holdhoff, Matthias, et al.
Publicado: (2018) -
Molecular Imaging of Metabolic Reprograming in Mutant IDH Cells
por: Viswanath, Pavithra, et al.
Publicado: (2016) -
Association of hyperglycemia and molecular subclass on survival in IDH-wildtype glioblastoma
por: Liu, Elisa K, et al.
Publicado: (2022)